Background: The causes of volatile anesthetic-induced cerebral vasodilation
include direct effects on smooth muscle and indirect effects via changes i
n metabolic rate and release of mediators from vascular endothelium and bra
in parenchyma. The role of nitric oxide and the relative importance of neur
onal and endothelial nitric oxide synthase (nNOS and eNOS, respectively) ar
e unclear.
Methods: Rat brain slices were superfused with oxygenated artificial cerebr
ospinal fluid. Hippocampal arteriolar diameters were measured using compute
rized videomicrometry. Vessels were preconstricted with prostaglandin F-2 a
lpha (PGF(2 alpha); halothane group) or pretreated with 7-nitroindazole sod
ium (7-NINA, specific nNOS inhibitor, 7-NINA + halothane group) or N-nitro-
L-arginine methylester CL-NAME; nonselective NOS inhibitor, L-NAME + haloth
ane group) and subsequently given PGF(2+) to achieve the same total precons
triction as in the halothane group. Increasing concentrations of halothane
were administered and vasodilation was calculated as a percentage of precon
striction.
Results: Halothane caused significant, dose-dependent dilation of hippocamp
al microvessels (halothane group). Inhibition of nNOS by 7-NINA or nNOS + e
NOS by L-NAME similarly attenuated halothane-induced dilation at 0.6, 1.6,
and 2.6% halothane. The dilation (mean +/- SEM) at 1.6% halothane was 104 /- 10%, 65 +/- 6%, and 51 +/- 9% in the halothane, 7-NINA + halothane and L
-NAME + halothane groups, respectively. The specificity of 7-NINA was confi
rmed by showing that acetylcholine-induced dilation was not inhibited by 7-
NINA but was converted to constriction by L-NAME.
Conclusions: At clinically relevant concentrations, halothane potently dila
tes intracerebral arterioles, This dilation is mediated, in part, by neuron
ally derived nitric oxide. Endothelial NOS does not play a major role in ha
lothane-induced dilation of hippocampal microvessels.